Works matching IS 11732563 AND DT 2019 AND VI 39 AND IP 11
Results: 12
Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 11, p. 1057, doi. 10.1007/s40261-019-00831-3
- By:
- Publication type:
- Article
Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 11, p. 1045, doi. 10.1007/s40261-019-00858-6
- By:
- Publication type:
- Article
Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its Use.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 11, p. 1141, doi. 10.1007/s40261-019-00853-x
- By:
- Publication type:
- Article
Effect of Combination Therapy of Endothelin Receptor Antagonist and Phosphodiesterase-5 Inhibitor on Clinical Outcome and Pulmonary Haemodynamics in Patients with Pulmonary Arterial Hypertension: A Meta-Analysis.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 11, p. 1031, doi. 10.1007/s40261-019-00841-1
- By:
- Publication type:
- Article
Tropicamide/Phenylephrine/Lidocaine Intracameral Injection: A Review in Cataract Surgery.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 11, p. 1133, doi. 10.1007/s40261-019-00843-z
- By:
- Publication type:
- Article
Changes in Prescription of Psychotropic Drugs After Introduction of Polypharmacy Reduction Policy in Japan Based on a Large-Scale Claims Database.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 11, p. 1077, doi. 10.1007/s40261-019-00838-w
- By:
- Publication type:
- Article
Single-Dose Pharmacokinetics and Tolerability of Aprocitentan, a Dual Endothelin Receptor Antagonist, in Subjects with Severe Renal Function Impairment.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 11, p. 1117, doi. 10.1007/s40261-019-00837-x
- By:
- Publication type:
- Article
The Respimat<sup>®</sup> Soft Mist Inhaler: Implications of Drug Delivery Characteristics for Patients.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 11, p. 1021, doi. 10.1007/s40261-019-00835-z
- By:
- Publication type:
- Article
Prophylactic Sildenafil in Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Pilot Randomized, Double-Blinded, Placebo-Controlled Trial.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 11, p. 1093, doi. 10.1007/s40261-019-00834-0
- By:
- Publication type:
- Article
Pharmacokinetics and Safety of Posaconazole Administered by Intravenous Solution and Oral Tablet in Healthy Chinese Subjects and Effect of Food on Tablet Bioavailability.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 11, p. 1109, doi. 10.1007/s40261-019-00833-1
- By:
- Publication type:
- Article
Individualized Protease Inhibitor Monotherapy: The Role of Pharmacokinetics and Pharmacogenetics in an Aged and Heavily Treated HIV-Infected Patient.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 11, p. 1125, doi. 10.1007/s40261-019-00829-x
- By:
- Publication type:
- Article
Comprehensive Real-World Assessment of Marketed Medications to Guide Parkinson's Drug Discovery.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 11, p. 1067, doi. 10.1007/s40261-019-00830-4
- By:
- Publication type:
- Article